Journal of Psychopharmacology
May 2017
Vincent D Pisano, Nathaniel P Putnam, Hannah M. Kramer et al.
Preliminary studies show psychedelic compounds administered with psychotherapy are potentially effective and durable substance misuse interventions. However, little is known about the association between psychedelic use and substance misuse in the general population. This study investigated the association between psychedelic use and past year opioid use disorders within illicit opioid users....
Pharmacopsychiatry
April 25, 2017
Norbert Scherbaum, Fabrizio Schifano, Udo Bonnet
46 citations
Over the last few years, hundreds of new psychoactive substances (NPS) have been identified in Europe. Apart from some herbal compounds, NPS mainly include synthetic cannabinoids and a range of new synthetic stimulants (e. g., cathinones). Synthetic NPS are often developed whilst modifying the basic chemical (e. g., phenethylamine or tryptamine) structure. Although the pharmacology and...
Eat, Sleep, Work
April 20, 2017
Craig Cameron Hicks
Background: Post traumatic stress disorder (PTSD) and alcohol comorbidity is becoming a rising issue within the military veteran community highlighted by research indicating individuals diagnosed with PTSD are more likely to have a drinking problem [1]. The implementation of meditation as an alternative form of stress release was aimed at reducing PTSD symptomology and therefor reducing factors...
International Journal of Drug Policy
April 19, 2017
Piera Talin, Emilia Sanabria
101 citations
The ritual use of ayahuasca stands in strong contrast to hegemonic understandings of addiction, paving new ground between the overstated difference between community and pharmacological interventions. The article concludes that fluid, adaptable forms of caregiving play a key role in the success of addiction recovery and that feeling part of a community has an important therapeutic potential.
Drug and Alcohol Review
April 10, 2017
Stephen Bright, M.l. Williams, David Caldicott
5 citations
As recently noted by Strauss, Bright and Williams 1, while much of the Western world has been experiencing a renaissance in research into ‘psychedelic science’ over the past decade 2, there has been no such research conducted in Australia. In Europe and the USA, studies have been conducted into lysergic acid diethylamide (LSD) that have improved our understanding of brain function 3 and reduced...
Trials
April 4, 2017
Amy Mcandrew, Will Lawn, Tobias Stevens et al.
20 citations
BACKGROUND: Worldwide, alcohol abuse is a burgeoning problem. Abstinence is key to allow recovery of physical and mental health as well as quality of life, but treatment for alcohol dependence is associated with high relapse rates. Preliminary data have suggested that a combined repeated ketamine and psychological therapy programme may be effective in reducing relapse in severe alcohol use...
Neuropsychopharmacology
April 2017
Erin K Kirschmann, Michael W Pollock, Vidhya Nagarajan et al.
Use of marijuana (Cannabis sativa) often begins in adolescence, and heavy adolescent marijuana use is often associated with impaired cognitive function in adulthood. However, clinical reports of long-lasting cognitive deficits, particularly in subjects who discontinue use in adulthood, are mixed. Moreover, dissociating innate differences in cognitive function from cannabis-induced deficits is...
The International Journal of Neuropsychopharmacology
April 1, 2017
Katie Walsh, Ravi Das, Sunjeev K. Kamboj
Healthy people with a family history of alcohol problems show a pattern of subjective responses to alcohol that resemble those of affected probands. Studies on ketamine suggest that up-regulation of N-methyl-D-aspartate receptors (NMDARs) underlies these effects, and point to a pharmacologically-responsive endophenotype reflecting enhanced risk for alcohol-use disorders. Subjective stimulant...
Journal of Psychedelic Studies
April 1, 2017
Ben Sessa
Treating people with alcohol use disorder has been an important target area for psychedelic research – both in the first studies of the 1950s and during the Psychedelic Renaissance of the last 10 years. To date, most studies have looked at the classical psychedelic drugs as adjuncts to psychotherapy; with attention paid to the psychospiritual aspect of the experience as a central therapeutic...
Journal of Psychedelic Studies
April 1, 2017
Eduardo Ekman Schenberg, Maria Angélica de Castro Comis, João Felipe Morel Alexandre et al.
29 citations
Substance use disorders are important contributors to the global burden of disease, but current treatments are not associated with high rates of recovery. The lack of approved and effective treatments is acutely problematic for psychostimulants like cocaine and crack cocaine. One promising alternative in the treatment of drug dependence in general and psychostimulants in particular is the use...